Because of this, CCL2 overexpression can induce tumor metastasis, invasion, and the development of immune resistance, and in cancer patients, it characterizes a poor prognosis due to immunosuppressive cell subtype accumulation [16]. This evidence concerns the gene CCL2 and cancer.